ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values

Lin, Han; Yang, Yong; Hou, Chongxian; Zheng, Jiantao; Lv, Guangzhao; Mao, Rui; Xu, Peihong; Chen, Shanwei; Zhou, Yujun; Wang, Peng*; Zhou, Dong*广东省人民医院; 南方医科大学; 汕头大学
American Journal of Translational Research2021
8被引8阅读
引用收藏
分享

摘要

Glioma, a highly aggressive neuroepithelial malignant brain tumor, is associated with high disability and recurrence rates. Enhancer RNA (eRNA) plays a significant role in tumor proliferation and metastasis; however, their functions in gliomas need further evaluation. We used the computational pipeline, PreSTIGE, to predict tissue-specific enhancer-derived RNAs and the underlying regulatory genes. Using data retrieved from the TCGA and CGGA databases, a LASSO regression analysis and multiCox proportional hazards regression analyses were performed to determine the hub eRNAs associated with glioma prognosis. Quantitative reverse transcription PCR was performed on the glioma samples to evaluate the expression characteristics of the identified hub eRNAs. To construct a risk signature, we selected three eRNAs, including CRNDE, MRPS31P5, and LINC00844, for their significant prognostic values. The predictive value of the risk signature was validated using the CGGA and Rembrandt cohorts. Apart from the risk signature, the nomogram performed well at predicting OS in glioma patients. An eRNA-target gene regulatory network was established, which we evaluated using a target gene enrichment analysis. Pathway and gene ontology (GO) analyses demonstrated that the risk signature is associated with mRNA processing and spliceosome in glioma. Furthermore, we found that hub eRNAs potentially regulate the expressions of numerous splicing factors, such as MOV10 and SEC31B, and are correlated with prognosis-associated alteration splicing (AS). In conclusion, we established a risk signature that comprises three eRNAs, which can accurately be utilized as targets to predict prognosis in glioma patients.

学科与关键词

关键词
Enhancer RNAgliomaprognosisalternative splicingsplicing factor
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
American Journal of Translational Research
发表日期
2021
卷期
第 13 卷, 第 8 期
页码
8611-8631
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81901250]; High-Level Hospital Construction Project of Guangdong Province, China [DFJH201924]; Natural Science Foundation of Guangdong Province, China [2018A0303130236]

作者

  • L

    Lin, Han (第一作者)

    shantou univ · guangdong prov peoples hosp

  • Y

    Yang, Yong

    guangdong prov peoples hosp

查看全部 11 位作者收起作者
  • H

    Hou, Chongxian

    guangdong prov peoples hosp

  • Z

    Zheng, Jiantao

    guangdong prov peoples hosp

  • L

    Lv, Guangzhao

    shantou univ · guangdong prov peoples hosp

  • M

    Mao, Rui

    guangdong prov peoples hosp

  • X

    Xu, Peihong

    shantou univ · guangdong prov peoples hosp

  • C

    Chen, Shanwei

    shantou univ · guangdong prov peoples hosp

  • Z

    Zhou, Yujun

    southern med univ · guangdong prov peoples hosp

  • W

    Wang, Peng (通讯)

    guangdong prov peoples hosp

  • Z

    Zhou, Dong (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417